# Supplementation of L-arginine in Patients With Non-resectable Brain Metastases

> **NCT02844387** · PHASE1,PHASE2 · COMPLETED · sponsor: **Instituto de Oncología Ángel H. Roffo** · enrollment: 70 (actual)

## Conditions studied

- Unresectable Multiple Brain Metastases

## Interventions

- **DIETARY_SUPPLEMENT:** L-arginine hydrochloride solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02844387
- **Lead sponsor:** Instituto de Oncología Ángel H. Roffo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2007-11
- **Final completion:** 2008-12
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2016-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844387, "Supplementation of L-arginine in Patients With Non-resectable Brain Metastases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02844387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*